Researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD) by using the latest technologies, including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells
Washington D.C [US], Dec. 3 (ANI): A recent study suggests that two recently discovered genetic differences between brain cancer cells and normal tissue cells could offer clues to tumor behavior and potential new targets for therapy.